Health & Fitness

A rare immune disorder has inspired a potential universal antiviral therapy. By mimicking the mutation s unique inflammation signature, researchers developed an mRNA-based treatment that stopped influenza and COVID-19 in animal trials.

from Top Health News -- ScienceDaily https://ift.tt/XncZUJp

A sweeping review of 67 trials has cast doubt on the use of ketamine and similar NMDA receptor antagonists for chronic pain relief. While ketamine is frequently prescribed off-label for conditions like fibromyalgia and nerve pain, researchers found little convincing evidence of real benefit and flagged serious side effects such as delusions and nausea. The lack of data on whether it reduces depression or opioid use adds to the uncertainty.

from Top Health News -- ScienceDaily https://ift.tt/oJOvVxB